C3 and glomerulosclerosis: Turnberg et al. have reported that the C3 deficient adriamycin nephropathy mice showed a delay of the onset of detectable albuminuria, a reduction of foot-processes effacement, thus a less glomerulosclerosis and less tubulointersititial scarring, and better renal function for a long-time observation [14].